�鶹Ů��

The Biden administration announced Tuesday that states will share $5.8 billion in federal funds for water infrastructure projects around the country. ... Vice President Kamala Harris, who traveled to Pittsburgh to make the announcement, said everyone in the U.S. should be able to have clean water. ... The White House said Tuesday’s announcement includes $3.2 billion for what’s known as the Drinking Water State Revolving Fund that can be used for upgrades to water treatment plants, water distribution and piping systems, and lead pipe replacement. (2/20)

Jill Biden on Wednesday was announcing $100 million in federal funding for research and development into women’s health as part of a new White House initiative that she is heading up. The funding is the first major deliverable of the White House Initiative on Women’s Health Research, which was announced late last year. The money comes from the Advanced Research Projects Agency for Health, or ARPA-H, which is under the federal Department of Health and Human Services. (Superville, 2/21)

Some safety-net hospitals will receive lower Medicaid disproportionate share hospital payments under a final rule the Centers for Medicare and Medicaid Services published Tuesday. The regulation sets new restrictions on how Medicaid DSH payments are calculated and distributed, carrying out a congressional directive from the Consolidated Appropriations Act of 2021. (Kacik, 2/20)

An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products. Triple-check your data or we’ll reject your device, the FDA warned. (Lawrence, 2/20)

The amount of in-network care patients received across different specialties and settings jumped significantly as surprise billing protections took effect, according to a FAIR Health analysis shared first with Axios. (Reed, 2/20)

Usually the words generative AI in health are followed by a bold claim. The technology will transform some aspect of care delivery, save gobs of money, or automate administrative tasks crucial to connecting patients with timely services. Rohit Chandra, chief digital officer of the Cleveland Clinic, said generative AI can accomplish all these things. But he also said this: “Harm is not just likely. It is for sure going to happen.” (Palmer and Ross, 2/21)

A U.S. appeals court revived a controversial lawsuit brought by nearly two dozen people who claimed they were harmed by a contaminated rare disease medicine sold by a Sanofi subsidiary and a subsequent rationing plan that only worsened their health. And if some upcoming procedural hurdles are cleared, the suit may shine a light on an unusual patient dilemma when a drug is in short supply. (Silverman, 2/20)